ThermaClear
This article was originally published in The Rose Sheet
Executive Summary
FDA has given clearance to Therative to market its ThermaClear hand-held acne treatment device, the company announces Jan. 16. Therative has also finished an additional round of expansion funding in anticipation of the product's launch, raising $5 mil. from three venture capital firms. ThermaClear is designed for home treatment of mild-to-moderate acne. It utilizes proprietary technology based on the laser treatments used by dermatologists. The device wears the start-up's first consumer brand; it will be launched in a line that includes a number of topical acne treatment products...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.